Study Title
Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (SIMPLICITY)
Purpose
To compare the efficacy of 2 different treatments in patients with Chronic Phase CML as measured by major molecular response (MMR) rate at 12 months.
Eligibility
Male or female patients ≥ 18 years old
Newly diagnosed , within 6 months of diagnosis with Chronic Phase CML
Not received any prior treatment for Chronic Phase CML
Study Process
Subjects will be followed every Cycle on Days 1,8,15,28.
Treatment medication will be provided
Trial Details
Investigator:
Michael Moore, M.D.
IRB:
Copernicus
IRB Number:
Trial Type:
Drug
Sponsor:
Bistrol Myers Squibb
Contact Information:
Hematology Oncology Associates
(318) 212-8620
http://cancer.wkhs.com